Addus HomeCare Co. (NASDAQ:ADUS) Shares Sold by Axa S.A.

Axa S.A. lessened its stake in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 84.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,990 shares of the company’s stock after selling 21,617 shares during the quarter. Axa S.A.’s holdings in Addus HomeCare were worth $500,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of the stock. Lido Advisors LLC boosted its stake in shares of Addus HomeCare by 60.7% during the fourth quarter. Lido Advisors LLC now owns 2,671 shares of the company’s stock valued at $335,000 after acquiring an additional 1,009 shares during the last quarter. Northern Trust Corp boosted its stake in shares of Addus HomeCare by 3.3% during the 4th quarter. Northern Trust Corp now owns 285,872 shares of the company’s stock worth $35,834,000 after purchasing an additional 9,122 shares during the last quarter. Susquehanna Fundamental Investments LLC purchased a new stake in shares of Addus HomeCare during the fourth quarter worth about $1,716,000. Nebula Research & Development LLC raised its position in shares of Addus HomeCare by 90.5% in the fourth quarter. Nebula Research & Development LLC now owns 14,225 shares of the company’s stock valued at $1,783,000 after buying an additional 6,757 shares during the last quarter. Finally, Oberweis Asset Management Inc. lifted its stake in shares of Addus HomeCare by 23.5% during the fourth quarter. Oberweis Asset Management Inc. now owns 59,900 shares of the company’s stock valued at $7,508,000 after buying an additional 11,400 shares during the period. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Addus HomeCare Stock Performance

NASDAQ ADUS opened at $110.91 on Friday. Addus HomeCare Co. has a one year low of $88.96 and a one year high of $136.72. The company’s 50 day moving average price is $98.86 and its 200 day moving average price is $114.47. The firm has a market capitalization of $2.04 billion, a price-to-earnings ratio of 25.38, a PEG ratio of 1.41 and a beta of 0.85.

Addus HomeCare (NASDAQ:ADUS) last posted its earnings results on Monday, May 5th. The company reported $1.42 earnings per share for the quarter, beating the consensus estimate of $1.33 by $0.09. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business had revenue of $337.71 million for the quarter, compared to analyst estimates of $341.66 million. During the same quarter in the previous year, the business posted $1.21 EPS. The business’s quarterly revenue was up 20.3% on a year-over-year basis. Sell-side analysts forecast that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.

Analysts Set New Price Targets

ADUS has been the subject of several analyst reports. Macquarie boosted their price target on Addus HomeCare from $129.00 to $133.00 and gave the company an “outperform” rating in a report on Thursday. Stephens reiterated an “overweight” rating and issued a $142.00 target price on shares of Addus HomeCare in a research note on Wednesday, March 12th. StockNews.com lowered Addus HomeCare from a “buy” rating to a “hold” rating in a research note on Wednesday, February 26th. JMP Securities reiterated a “market outperform” rating and set a $150.00 price objective on shares of Addus HomeCare in a report on Tuesday, April 22nd. Finally, Oppenheimer boosted their target price on shares of Addus HomeCare from $145.00 to $150.00 and gave the company an “outperform” rating in a report on Friday, January 24th. One equities research analyst has rated the stock with a hold rating, six have issued a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, Addus HomeCare has a consensus rating of “Buy” and a consensus target price of $142.57.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.